Submission of statement of deviation for the half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vrundavan Plantation has confirmed to BSE that there is no deviation or variation in the use of funds raised through the preferential issue of warrants. The company allotted 8,56,872 equity shares on conversion of warrants originally issued on February 17, 2025, with the balance 75% warrant exercise amount of Rs. 3.28 crore received on August 1, 2025. Out of the original allocation of Rs. 437 lakhs earmarked for long-term working capital and general corporate purposes, Rs. 327.75 lakhs has been utilised so far. The Audit Committee reviewed and approved the statement at its meeting on November 11, 2025. No monitoring agency was appointed, and the filing is a routine half-yearly compliance requirement under SEBI Listing Regulations.
This is a routine regulatory compliance filing with no negative implications — it simply confirms the company used the Rs. 3.28 crore raised as originally planned. No material impact on stock price or shareholder value is expected; it reinforces governance and fund-utilisation transparency.